Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Flortaucipir F18

Flortaucipir F18

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Flortaucipir F18

17 trials tracked of Flortaucipir F18: 3 in phase 3 or 4 and 3 with published results. The most-cited published study has 442 citations.

17Trials tracked
3Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 3 3 Phase 2 5 Phase 1 9
  1. Phase 3 18F-AV-1451 Autopsy Study Completed · 442 cited
  2. Phase 3 Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects Completed · 53 cited
  3. Phase 3 Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease Completed · 53 cited
  4. Phase 2 Clinical Evaluation of Flortaucipir F 18 Completed
  5. Phase 2 18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy Completed
  6. Phase 2 Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05 Completed
Show 11 more trials
  1. Phase 2 Tau Screening Study in Subjects With Early Symptomatic AD Completed
  2. Phase 2 Tau Screening Study in Patients With Early Symptomatic AD Completed
  3. Phase 1 Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease Completed
  4. Phase 1 A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects Completed
  5. Phase 1 A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease Completed
  6. Phase 1 Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects Completed
  7. Phase 1 Tau Imaging in Professional Fighters Completed
  8. Phase 1 Flortaucipir PET Imaging in Subjects With FTD Completed
  9. Phase 1 18F-AV-1451 High Resolution Autopsy Study Completed
  10. Phase 1 Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers Completed
  11. Phase 1 Augmenting Flortaucipir Dosimetry Estimates Completed

Showing the 17 most-cited and recently-updated of 17 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.